Mihoko Matsumura Selected Research

Mihoko Matsumura Research Topics

8	Type 2 Diabetes Mellitus (MODY) 04/2021 - 06/2009
2	Hyperlipidemias (Hyperlipidemia) 02/2011 - 01/2010
1	Weight Loss (Weight Reduction) 04/2021
1	Hypertrophy 08/2015
1	Fibrosis (Cirrhosis) 08/2015
1	Diabetes Mellitus 10/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2013
1	Inflammation (Inflammations) 02/2011
1	Hypercalcemia (Milk Alkali Syndrome) 01/2011
1	Humoral Hypercalcemia Of Malignancy 01/2011
1	Postmenopausal Osteoporosis 01/2010
1	Hypertriglyceridemia 06/2009
1	Hyperglycemia 06/2009
1	Hematoma 01/2006
1	Hyperthyroidism 01/2006
1	Hypokalemia 01/2006
1	Paralysis (Palsy) 01/2006
1	Ventricular Fibrillation 01/2006

5	Insulin (Novolin)FDA Link 04/2021 - 10/2013
4	Glucose (Dextrose)FDA LinkGeneric 12/2017 - 06/2009
2	CanagliflozinIBA 12/2017 - 08/2017
2	LDL CholesterolIBA 02/2011 - 01/2010
2	oxidized low density lipoproteinIBA 02/2011 - 01/2010
2	Triglycerides (Triacylglycerol)IBA 01/2010 - 06/2009
1	Liraglutide FDA Link 04/2021
1	insulin aspart drug combination insulin degludecIBA 04/2021
1	insulin degludecIBA 04/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2021
1	Blood Glucose (Blood Sugar)IBA 08/2017
1	CollagenIBA 08/2015
1	Insulin Aspart (NovoLog)FDA Link 12/2014
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 12/2014
1	Insulin Lispro (Humalog)FDA Link 12/2014
1	pitavastatin (itavastatin)FDA Link 02/2011
1	Rosuvastatin Calcium (Crestor)FDA Link 02/2011
1	LipidsIBA 02/2011
1	Parathyroid Hormone-Related ProteinIBA 01/2011
1	CalciumIBA 01/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2010
1	HDL CholesterolIBA 01/2010
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2010
1	Acarbose FDA LinkGeneric 06/2009
1	voglibose (Basen)IBA 06/2009
1	Glycoside Hydrolase InhibitorsIBA 06/2009
1	Methylprednisolone FDA LinkGeneric 01/2006
1	SteroidsIBA 01/2006